Shun Shinomiya
Saitama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Successful Introduction of Lorlatinib After Drug Eruption With Alectinib in ALK-Positive Lung Adenocarcinoma: A Case Report.
Journal: Respirology case reports
Published: March 16, 2026
Assays for surface antigens in extracellular vesicles using proximity labeling strategy.
Journal: Methods in cell biology
Published: November 23, 2025
Evaluating the Diagnostic Value of Lymphocyte Subsets in Bronchoalveolar Lavage Fluid and Peripheral Blood Across Various Diffuse Interstitial Lung Disease Subtypes.
Journal: Biomolecules
Published: December 13, 2024
Nintedanib-associated enterocolitis with intractable diarrhea: a case report.
Journal: Clinical journal of gastroenterology
Published: October 05, 2023
Improvement of sleep parameters by titration polysomnography could predict adherence to positive airway pressure therapy in obstructive sleep apnea.
Journal: Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine
Published: April 21, 2023
Prospective assessment using 18F-FDG PET/CT as a novel predictor for early response to PD-1 blockade in non-small-cell lung cancer.
Journal: Scientific reports
Published: March 26, 2022
Effect of Systemic Steroid Use for Immune-Related Adverse Events in Patients with Non-Small Cell Lung Cancer Receiving PD-1 Blockade Drugs.
Journal: Journal of clinical medicine
Published: July 20, 2021
Yellow Nail Syndrome in Which Intranodal Lymphangiography Contributed to the Diagnosis.
Journal: Internal medicine (Tokyo, Japan)
Published: June 07, 2021
Combination of immune check inhibitor and immunomodulatory arabinomannan extracted from Mycobacterium tuberculosis: A case report.
Journal: Molecular and clinical oncology
Published: March 05, 2021
Synchronous dilemma of sarcoid-like reaction and drastic response after PD-1 blockade administration in lung cancer.
Journal: Japanese journal of clinical oncology
Published: February 16, 2021
Clinical impact of post-progression survival on overall survival in patients receiving nivolumab monotherapy as a second-line treatment for advanced non-small cell lung cancer.
Journal: Thoracic cancer
Published: December 30, 2020
Last Updated: 09/26/2026